Alcon EBITDA Margin 2019-2022 | ALC

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Alcon (ALC) over the last 10 years. The current EBITDA margin for Alcon as of June 30, 2022 is .
Alcon EBITDA Margin Historical Data
2022-06-30 $8.66B $1.93B 22.25%
2022-03-31 $8.55B $1.88B 21.94%
2021-12-31 $8.29B $1.80B 21.71%
2021-09-30 $8.08B $1.92B 23.74%
2021-06-30 $7.82B $1.77B 22.60%
2021-03-31 $6.92B $1.23B 17.70%
2020-12-31 $6.83B $1.14B 16.74%
2020-09-30 $6.81B $0.90B 13.16%
2020-06-30 $6.84B $0.95B 13.84%
2020-03-31 $7.53B $1.32B 17.55%
2019-12-31 $7.51B $1.27B 16.90%
2019-06-30 $5.49B $1.00B 18.15%
2019-03-31 $5.41B $0.73B 13.43%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $29.415B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.040B 20.78
Edwards Lifesciences (EW) United States $52.534B 37.17
STERIS (STE) Ireland $16.731B 20.78
Teleflex (TFX) United States $9.732B 15.51
Fresenius Medical Care AG KGaA (FMS) Germany $8.433B 7.78
Penumbra (PEN) United States $7.007B 840.64
Globus Medical (GMED) United States $5.801B 29.59
Glaukos (GKOS) United States $2.385B 0.00
Integer Holdings (ITGR) United States $2.051B 16.04
Nevro (NVRO) United States $1.548B 0.00
Paragon 28 (FNA) United States $1.343B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.035B 15.85
Artivion (AORT) United States $0.537B 51.19